XML 74 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional paid in capital
(Accumulated Deficit)
Total
Balance at Dec. 31, 2017 $ 28 $ 30,555 $ (26,231) $ 4,352
Balance, Shares at Dec. 31, 2017 2,752,742      
Common stock issued as dividend      
Common stock issued as dividend, Shares 45,856      
Issuance of warrants with debt extension   809   809
Shares issued upon conversion of preferred stock 125   125
Shares issued upon conversion of preferred stock, Shares 16,339      
Shares issued upon conversion of preferred stock in public offering $ 18 1,784   1,802
Shares issued upon conversion of preferred stock in public offering, Share 1,846,928      
Shares issued upon conversion of promissory notes in public offering $ 20 10,031 10,051
Shares issued upon conversion of promissory notes in public offering, Shares 2,039,152      
Stock-based compensation   383   383
Vesting of performance shares granted to CEO $ 29 8,890   8,919
Vesting of performance shares granted to CEO Shares 2,857,142      
Net income (loss)     (10,620) (10,620)
Balance at Dec. 31, 2018 $ 97 53,575 (36,851) 16,821
Balance, Shares at Dec. 31, 2018 9,724,826      
Adjustment due to adoption of ASU 2016-02 (Topic 842, Leases)     171 171
Shares issued for services 30   30
Shares issued for services, Shares 17,960      
Shares issued to directors as compensation $ 1 62   63
Shares issued to directors as compensation, Shares 31,760      
Stock-based compensation   135   135
Vesting of performance shares granted to CEO   250   250
Net income (loss)     1,038 1,038
Balance at Dec. 31, 2019 $ 98 $ 54,052 $ (35,642) $ 18,508
Balance, Shares at Dec. 31, 2019 9,774,546